Peripartum cardiomyopathy (A literature review)
Heart failure (HF) is a serious and growing public health concern, which has many causes. Pregnancy is a critical condition with significant hemodynamic and immunologic changes. Peripartum cardiomyopathy (PPCM) is a disease of unknown cause in which left ventricular (LV) dysfunction occurs during th...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mashhad University of Medical Sciences
2014-10-01
|
| Series: | Reviews in Clinical Medicine |
| Subjects: | |
| Online Access: | https://rcm.mums.ac.ir/article_3159_4bc5add41299d1d435524eddb89fcab3.pdf |
| _version_ | 1797976004406280192 |
|---|---|
| author | Farveh Vakilian Fateme Tara Fateme Moosavi |
| author_facet | Farveh Vakilian Fateme Tara Fateme Moosavi |
| author_sort | Farveh Vakilian |
| collection | DOAJ |
| description | Heart failure (HF) is a serious and growing public health concern, which has many causes. Pregnancy is a critical condition with significant hemodynamic and immunologic changes. Peripartum cardiomyopathy (PPCM) is a disease of unknown cause in which left ventricular (LV) dysfunction occurs during the last trimester of pregnancy or the early puerperium. PPCM is known to be the most common cardiovascular cause of severe complications in pregnancy. Risk factors for peripartum cardiomyopathy include advanced maternal age, twin pregnancy, smoking, pregnancy-related hypertension and preeclampsia, multiparity, African descent, and long-term tocolysis. Oxidative stress and some inflammatory markers have been diagnosed in PPCM pathophysiology. Recent observations have suggested that bromocriptine might favor recovery of LV systolic function in patients with PPCM. Patients developed peripartum cardiomiopathy treated with bromocriptine showed significantly improved LV ejection fraction and heart failure symptoms. This article tries to have a short review on this clinical scenario. |
| first_indexed | 2024-04-11T04:44:24Z |
| format | Article |
| id | doaj.art-56fd20e598dd449c98f763895c05a6ed |
| institution | Directory Open Access Journal |
| issn | 2345-6256 2345-6892 |
| language | English |
| last_indexed | 2024-04-11T04:44:24Z |
| publishDate | 2014-10-01 |
| publisher | Mashhad University of Medical Sciences |
| record_format | Article |
| series | Reviews in Clinical Medicine |
| spelling | doaj.art-56fd20e598dd449c98f763895c05a6ed2022-12-27T13:13:43ZengMashhad University of Medical SciencesReviews in Clinical Medicine2345-62562345-68922014-10-011419419910.17463/RCM.2014.04.0053159Peripartum cardiomyopathy (A literature review)Farveh Vakilian0Fateme Tara1Fateme Moosavi2Preventive Cardiovascular Care Research Center, Imam Reza Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IranPrenatal Care Research Center, School of Medicine, Omolbanin Hospital, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Gynecology, School of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, IranHeart failure (HF) is a serious and growing public health concern, which has many causes. Pregnancy is a critical condition with significant hemodynamic and immunologic changes. Peripartum cardiomyopathy (PPCM) is a disease of unknown cause in which left ventricular (LV) dysfunction occurs during the last trimester of pregnancy or the early puerperium. PPCM is known to be the most common cardiovascular cause of severe complications in pregnancy. Risk factors for peripartum cardiomyopathy include advanced maternal age, twin pregnancy, smoking, pregnancy-related hypertension and preeclampsia, multiparity, African descent, and long-term tocolysis. Oxidative stress and some inflammatory markers have been diagnosed in PPCM pathophysiology. Recent observations have suggested that bromocriptine might favor recovery of LV systolic function in patients with PPCM. Patients developed peripartum cardiomiopathy treated with bromocriptine showed significantly improved LV ejection fraction and heart failure symptoms. This article tries to have a short review on this clinical scenario.https://rcm.mums.ac.ir/article_3159_4bc5add41299d1d435524eddb89fcab3.pdfbromocriptineheart failureperi partum cardiomuopathy |
| spellingShingle | Farveh Vakilian Fateme Tara Fateme Moosavi Peripartum cardiomyopathy (A literature review) Reviews in Clinical Medicine bromocriptine heart failure peri partum cardiomuopathy |
| title | Peripartum cardiomyopathy (A literature review) |
| title_full | Peripartum cardiomyopathy (A literature review) |
| title_fullStr | Peripartum cardiomyopathy (A literature review) |
| title_full_unstemmed | Peripartum cardiomyopathy (A literature review) |
| title_short | Peripartum cardiomyopathy (A literature review) |
| title_sort | peripartum cardiomyopathy a literature review |
| topic | bromocriptine heart failure peri partum cardiomuopathy |
| url | https://rcm.mums.ac.ir/article_3159_4bc5add41299d1d435524eddb89fcab3.pdf |
| work_keys_str_mv | AT farvehvakilian peripartumcardiomyopathyaliteraturereview AT fatemetara peripartumcardiomyopathyaliteraturereview AT fatememoosavi peripartumcardiomyopathyaliteraturereview |